ATRC
AtriCure, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Buy
+37/100
Last price
53.68
▼ 2.69 (4.77%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
56.45
Prev close
56.37
Day high
56.58
Day low
53.43
Volume
863.66K
Market cap
$2.73B
P/E (TTM)
255.62
52W range
25.36 – 61.70
Day trading desk
Gap from prior close
+0.14%
Prior close 56.37
VWAP
54.02
-0.62% from price
Relative volume
1.26×
Normal
Session range
7.12%
53.20 – 56.99
Position in range
13%
Near session low
ATR (14D)
2.64
4.93% of price
Prior day high
56.60
PDH
Prior day low
53.86
PDL
Bid / ask spread
—
Quote not published
Session volume
1.37M
Avg 1.09M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.53%
-9.5%
1M
+4.19%
+3.0%
3M
+59.48%
+55.0%
6M
+85.81%
+67.6%
YTD
+35.69%
+21.4%
1Y
+54.21%
+37.8%
3Y
+22.56%
-59.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ATRC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-945
Net selling
Buy transactions
15
81.92K shares
Sell transactions
12
82.87K shares
Net transactions
+27
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
1.91M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 23, 26 | PRIVITERA SALVATORE Chief Technology Officer |
SELL | 4.52K | $271.14K | Direct |
| Sep 11, 26 | GROVES REGINA E Director |
SELL | 5.31K | $288.07K | Direct |
| Sep 8, 26 | PRIVITERA SALVATORE Chief Technology Officer |
SELL | 3.66K | $201.13K | Direct |
| Sep 2, 26 | PRIVITERA SALVATORE Chief Technology Officer |
SELL | 7.76K | $407.56K | Direct |
| Aug 24, 26 | DAHLQUIST KARL S Officer |
SELL | 9.37K | $458.10K | Direct |
| Aug 5, 26 | PRANGE KAREN N. Director |
SELL | 3.56K | $138.28K | Direct |
| Aug 5, 26 | YUEN MAGGIE S. Director |
SELL | 3.50K | $134.47K | Direct |
| Jul 30, 26 | CARREL MICHAEL H Chief Executive Officer |
STOCK | 4.70K | $0 | Direct |
| Jul 29, 26 | NOZNESKY JUSTIN J Officer |
SELL | 6.18K | $239.86K | Direct |
| Jul 28, 26 | WEHRWEIN SVEN A Director |
CONVERSION | 25.00K | $498.75K | Direct |
| Jul 28, 26 | WEHRWEIN SVEN A Director |
SELL | 25.00K | $946.00K | Direct |
| Jul 28, 26 | DORAISWAMY VINAYAK Officer |
SELL | 6.00K | $233.28K | Direct |
| Jun 30, 26 | SEITH DOUGLAS J Chief Operating Officer |
STOCK | 527 | $12.53K | Direct |
| Jun 30, 26 | DORAISWAMY VINAYAK Officer |
STOCK | 636 | $15.12K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CARREL MICHAEL H |
Chief Executive Officer | 792.69K | Stock Gift |
DAHLQUIST KARL S |
Officer | 87.32K | Sale |
DORAISWAMY VINAYAK |
Officer | 86.51K | Sale |
JOHNSON B KRISTINE |
Director | 55.95K | Stock Award(Grant) |
NOZNESKY JUSTIN J |
Officer | 100.22K | Sale |
PRIVITERA SALVATORE |
Chief Technology Officer | 142.75K | Sale |
SEITH DOUGLAS J |
Chief Operating Officer | 229.87K | Stock Award(Grant) |
WHITE ROBERT S |
Director | 128.32K | Stock Award(Grant) |
WIRICK ANGELA L. |
Chief Financial Officer | 204.89K | Stock Award(Grant) |
YOUNT DEBORAH LEE |
Officer | 45.58K | Stock Award(Grant) |
Fundamentals
Market cap$2.73B
Enterprise value$2.64B
Revenue (TTM)$569.62M
Gross profit$434.61M
EBITDA$33.75M
Net income$10.55M
EPS (TTM)$0.21
Free cash flow$48.81M
Total cash$167.79M
Total debt$74.22M
Book value / share$10.15
Shares outstanding50.87M
Float48.83M
Short % of float8.76%
Dividend yield0.00%
Beta (5Y)1.25
Valuation & profitability ratios
Trailing P/E255.62
Forward P/E123.69
PEG ratio10.00
Price / sales—
Price / book5.29
EV / revenue4.63
EV / EBITDA78.14
Gross margin76.30%
Operating margin6.29%
Profit margin1.85%
Return on equity2.15%
Return on assets1.25%
Debt / equity14.37
Current ratio4.22
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $534.53M | $465.31M | $399.25M | $330.38M | +14.9% |
| Operating revenue | $534.53M | $465.31M | $399.25M | $330.38M | +14.9% |
| Cost of revenue | $133.75M | $117.78M | $98.88M | $84.44M | +13.6% |
| Gross profit | $400.78M | $347.52M | $300.37M | $245.94M | +15.3% |
| Research & development | $99.21M | $96.18M | $73.92M | $57.34M | +3.2% |
| Selling, general & admin | $311.02M | $291.36M | $253.14M | $231.27M | +6.7% |
| Total operating expense | $410.23M | $387.54M | $327.05M | $288.61M | +5.9% |
| Operating income | -$9.45M | -$40.01M | -$26.68M | -$42.67M | +76.4% |
| Pre-tax income | -$10.16M | -$43.67M | -$29.85M | -$46.20M | +76.7% |
| Tax provision | $1.28M | $1.02M | $591.00K | $268.00K | +25.5% |
| Net income | -$11.45M | -$44.70M | -$30.44M | -$46.47M | +74.4% |
| Net income to common | -$11.45M | -$44.70M | -$30.44M | -$46.47M | +74.4% |
| Basic EPS | -0.24 | -0.95 | -0.66 | -1.02 | +74.7% |
| Diluted EPS | -0.24 | -0.95 | -0.66 | -1.02 | +74.7% |
| EBIT | -$4.29M | -$37.27M | -$22.92M | -$41.21M | +88.5% |
| EBITDA | $16.25M | -$18.53M | -$8.11M | -$29.50M | +187.7% |
| Basic shares | 47.75M | 46.97M | 46.31M | 45.74M | +1.7% |
| Diluted shares | 47.75M | 46.97M | 46.31M | 45.74M | +1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $167.43M | $122.72M | $84.31M | $58.10M | +36.4% |
| Cash & short-term investments | $167.43M | $122.72M | $137.28M | $121.11M | +36.4% |
| Accounts receivable | $66.65M | $60.34M | $52.50M | $42.69M | +10.5% |
| Inventory | $78.49M | $75.33M | $67.90M | $45.93M | +4.2% |
| Total current assets | $322.52M | $267.83M | $266.25M | $215.21M | +20.4% |
| Goodwill & intangibles | $282.81M | $291.25M | $298.77M | $274.12M | -2.9% |
| Total assets | $654.18M | $609.33M | $613.93M | $585.45M | +7.4% |
| Total current liabilities | $81.52M | $73.42M | $74.57M | $58.39M | +11.0% |
| Current debt | — | $2.81M | $2.53M | $5.47M | — |
| Long-term debt | $61.87M | $61.87M | $60.59M | $56.83M | 0.0% |
| Total debt | $73.38M | $73.72M | $74.49M | $74.55M | -0.5% |
| Total liabilities | $162.24M | $148.36M | $147.76M | $128.69M | +9.4% |
| Retained earnings | -$413.20M | -$401.75M | -$357.06M | -$326.62M | -2.8% |
| Shareholder equity | $491.94M | $460.97M | $466.17M | $456.75M | +6.7% |
| Working capital | $241.00M | $194.40M | $191.68M | $156.82M | +24.0% |
| Net tangible assets | $209.13M | $169.72M | $167.40M | $182.63M | +23.2% |
| Shares issued | 49.79M | 48.87M | 47.53M | 46.56M | +1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$11.45M | -$44.70M | -$30.44M | -$46.47M | +74.4% |
| Depreciation & amortisation | $20.53M | $18.73M | $14.81M | $11.71M | +9.6% |
| Stock-based compensation | $44.69M | $40.41M | $35.73M | $28.77M | +10.6% |
| Change in working capital | -$4.29M | -$18.36M | -$18.24M | -$18.88M | +76.7% |
| Operating cash flow | $57.33M | $12.20M | $4.48M | -$22.14M | +369.8% |
| Capital expenditure | -$15.05M | -$23.46M | -$42.00M | -$16.88M | +35.8% |
| Investing cash flow | -$14.55M | $30.23M | $21.82M | $44.01M | -148.1% |
| Share buybacks | -$11.16M | -$6.95M | -$6.56M | -$12.20M | -60.6% |
| Dividends paid | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $1.18M | -$3.60M | -$32.00K | -$7.06M | +132.6% |
| Free cash flow | $42.28M | -$11.26M | -$37.51M | -$39.02M | +475.7% |
| End cash position | $167.43M | $122.72M | $84.31M | $58.10M | +36.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $153.60M | $141.25M | $140.50M | $134.27M | $136.14M | +8.7% |
| Operating revenue | $153.60M | $141.25M | $140.50M | $134.27M | $136.14M | +8.7% |
| Cost of revenue | $34.98M | $31.94M | $35.16M | $32.94M | $34.66M | +9.5% |
| Gross profit | $118.63M | $109.31M | $105.34M | $101.33M | $101.48M | +8.5% |
| Research & development | $26.40M | $24.23M | $24.50M | $22.89M | $29.28M | +8.9% |
| Selling, general & admin | $82.56M | $84.55M | $78.34M | $78.23M | $78.39M | -2.4% |
| Total operating expense | $108.96M | $108.78M | $102.85M | $101.12M | $107.67M | +0.2% |
| Operating income | $9.66M | $526.00K | $2.49M | $208.00K | -$6.19M | +1,737.5% |
| Net interest income | -$139.00K | -$95.00K | -$173.00K | -$303.00K | -$549.00K | -46.3% |
| Pre-tax income | $9.43M | $394.00K | $2.36M | -$86.00K | -$5.93M | +2,292.4% |
| Tax provision | $471.00K | $286.00K | $604.00K | $181.00K | $261.00K | +64.7% |
| Net income | $8.96M | $108.00K | $1.76M | -$267.00K | -$6.19M | +8,191.7% |
| Net income to common | $8.96M | $108.00K | $1.76M | -$267.00K | -$6.19M | +8,191.7% |
| Basic EPS | 0.18 | 0.00 | 0.04 | -0.01 | -0.13 | — |
| Diluted EPS | 0.18 | 0.00 | 0.04 | -0.01 | -0.13 | — |
| EBIT | $10.74M | $1.73M | $3.86M | $1.38M | -$4.44M | +519.6% |
| EBITDA | $16.05M | $7.01M | $8.97M | $6.55M | $732.00K | +129.1% |
| Basic shares | 48.67M | 48.33M | 48.87M | 47.92M | 47.72M | +0.7% |
| Diluted shares | 48.87M | 49.05M | 48.87M | 47.92M | 47.72M | -0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $167.79M | $146.16M | $167.43M | $147.87M | $117.80M | +14.8% |
| Cash & short-term investments | $167.79M | $146.16M | $167.43M | $147.87M | $117.80M | +14.8% |
| Accounts receivable | $79.98M | $71.31M | $66.65M | $62.98M | $66.00M | +12.2% |
| Inventory | $83.92M | $81.14M | $78.49M | $78.95M | $76.34M | +3.4% |
| Total current assets | $345.53M | $313.69M | $322.52M | $301.11M | $271.26M | +10.1% |
| Property, plant & equipment | $48.49M | $46.19M | $45.99M | $46.35M | $47.77M | +5.0% |
| Goodwill & intangibles | $278.04M | $280.42M | $282.81M | $284.92M | $287.03M | -0.9% |
| Total assets | $676.64M | $643.99M | $654.18M | $635.44M | $608.85M | +5.1% |
| Total current liabilities | $81.92M | $73.19M | $81.52M | $77.84M | $68.84M | +11.9% |
| Long-term debt | $61.00M | $61.00M | $61.87M | $61.87M | $61.87M | 0.0% |
| Total debt | $71.05M | $71.78M | $73.38M | $76.73M | $77.25M | -1.0% |
| Total liabilities | $160.21M | $152.29M | $162.24M | $158.94M | $144.36M | +5.2% |
| Retained earnings | -$404.14M | -$413.10M | -$413.20M | -$414.96M | -$414.69M | +2.2% |
| Shareholder equity | $516.43M | $491.69M | $491.94M | $476.51M | $464.49M | +5.0% |
| Working capital | $263.62M | $240.50M | $241.00M | $223.27M | $202.41M | +9.6% |
| Net tangible assets | $238.39M | $211.27M | $209.13M | $191.59M | $177.46M | +12.8% |
| Shares issued | 50.86M | 50.63M | 49.79M | 49.71M | 49.69M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $8.96M | $108.00K | $1.76M | -$267.00K | -$6.19M | +8,191.7% |
| Depreciation & amortisation | $5.31M | $5.27M | $5.11M | $5.17M | $5.17M | +0.6% |
| Stock-based compensation | $12.31M | $11.27M | $11.26M | $12.42M | $11.37M | +9.2% |
| Change in working capital | -$4.96M | -$21.46M | $137.00K | $8.86M | $6.33M | +76.9% |
| Operating cash flow | $22.19M | -$4.00M | $20.03M | $26.72M | $21.62M | +655.4% |
| Capital expenditure | -$3.77M | -$3.85M | -$2.60M | -$2.60M | -$7.66M | +2.2% |
| Investing cash flow | -$3.77M | -$3.85M | -$2.60M | -$2.60M | -$7.66M | +2.2% |
| Share buybacks | -$314.00K | -$11.44M | -$228.00K | -$357.00K | -$406.00K | +97.3% |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $3.26M | -$13.26M | $2.10M | $5.98M | $3.42M | +124.6% |
| Free cash flow | $18.43M | -$7.85M | $17.43M | $24.11M | $13.96M | +334.8% |
| End cash position | $167.79M | $146.16M | $167.43M | $147.87M | $117.80M | +14.8% |
Options analytics
Put / call volume
0.18
Call-heavy session
Put / call open interest
0.27
Positioning, not flow
Max pain
40.00
-25.5% from spot
ATM implied vol
89.7%
Nearest strike to spot
Skew (10% OTM)
-62.3%
Calls bid over puts
Call volume
99
Contracts, this expiry
Put volume
18
Contracts, this expiry
Heaviest call OI
40.00
141 contracts
Heaviest put OI
40.00
27 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.02 | 0.18 | +650.3% |
| Mar 2026 | -0.06 | 0.00 | +100.0% |
| Dec 2025 | -0.04 | 0.06 | +249.9% |
| Sep 2025 | -0.12 | -0.01 | +91.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.01 | 9 | $151.18M | +12.6% |
| Next quarter | 0.09 | 9 | $160.19M | +14.0% |
| Current year | 0.28 | 9 | $606.26M | +13.4% |
| Next year | 0.43 | 9 | $679.74M | +12.1% |
Analyst targets & ownership
Mean target$54.89
High target$65.00
Low target$36.00
Implied upside2.25%
Analyst count9
ConsensusBUY
Strong buy / Buy3 / 4
Hold3
Sell / Strong sell0 / 0
Held by insiders3.76%
Held by institutions105.82%
Institutions holding359
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
57.05
-5.92% from price
SMA 20
56.73
-5.38% from price
SMA 50
49.86
+7.65% from price
SMA 100
40.00
+34.19% from price
SMA 200
36.48
+47.15% from price
EMA 12
56.09
-4.29% from price
EMA 26
54.50
-1.51% from price
EMA 50
50.19
+6.95% from price
RSI (14)
48.0
Neutral
MACD (12,26,9)
1.58
Hist -1.01
ATR (14)
2.64
4.93% of price
Realised vol 30D
41.9%
Annualised
Bollinger upper
61.31
20, 2σ
Bollinger lower
52.15
20, 2σ
50 / 200 cross
Golden
49.86 vs 36.48
Trend bias
Above 200
+47.15%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.46
Less volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
41.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.0%
Peak to trough
Max drawdown 5Y
-77.2%
Peak to trough
ATR 14
2.64
4.93% of price
Beta (reported)
1.25
5Y monthly, from filing
Short interest
Shares short
4.28M
Prior 3.92M
Change vs prior
+9.1%
Shorts adding
% of float
8.76%
Normal
% of shares out
8.41%
Against total outstanding
Days to cover
4.5
Liquid
Float
48.83M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 26 | Freedom Capital Markets | DOWNGRADE | Buy | Hold |
| Sep 2, 26 | Needham | MAINTAINED | Buy | Buy |
| Aug 27, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 28, 26 | UBS | MAINTAINED | Buy | Buy |
| May 6, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 18, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 18, 26 | UBS | MAINTAINED | Buy | Buy |
| Feb 18, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Feb 18, 26 | Oppenheimer | DOWNGRADE | Outperform | Perform |
| Feb 18, 26 | BTIG | MAINTAINED | Buy | Buy |
| Feb 12, 26 | Needham | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Offering Registrations
S-8 · 2026-07-27
Corporate Changes & Voting Matters
8-K · 2026-07-23
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-27
Corporate Changes & Voting Matters
8-K · 2026-05-19
Periodic Financial Reports
10-Q · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-06
Periodic Financial Reports
10-K · 2026-02-19
Headlines
AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And Risks
Simply Wall St. · 2d ago
AtriCure (ATRC) Stock Looks Rich Against Its Sales Base
Simply Wall St. · 11d ago
Why AtriCure (ATRC) Is Back In The Spotlight
Simply Wall St. · 11d ago
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing
MT Newswires · 12d ago
AXT Inc. (AXTI) Climbs 16% on S&P 600 Addition
Insider Monkey · 15d ago
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Zacks · 23d ago
AtriCure CTO Sells 3,657 Shares
Motley Fool · 24d ago
Do Options Traders Know Something About AtriCure Stock We Don't?
Zacks · 27d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.